• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pre-metastatic Niche and Its Role in Lung Metastasis of Malignant Musculoskeletal Tumors

Research Project

Project/Area Number 20591754
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionOsaka University

Principal Investigator

HASHIMOTO Nobuyuki  Osaka University, 医学系研究科, 助教 (50324752)

Co-Investigator(Kenkyū-buntansha) MYOUI Akira  大阪大学, 医学部附属病院, 准教授 (10263261)
YOSHIKAWA Hideki  大阪大学, 医学研究科, 教授 (60191558)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords悪性骨軟部腫瘍 / 肺転移 / メカニズム / 骨肉腫 / NF-κB / ユビキチン修飾 / NF-kB / 直鎖状ユビキチン修飾 / 骨軟部腫瘍 / 微小環境
Research Abstract

We mainly investigated the precise function of a new ubiquitin ligase LUBAC involved in NFκB activation, which is a key molecular event in the early lung metastasis using LM8 murine osteosarcoma animal model. LUBAC was overexpressed in this highly metastatic subclone compared with the parental cells. The media obtained from lung organ culture also stimulated the expression. In the loss of function study, cell proliferation, motility and MMP-9 production was significantly reduced in vitro. And lung metastasis was also inhibited in vivo. When the tumor cells injected from the tail veins were observed by in vivo imaging system, the LUBAC knock-down cells were rapidly washed-out and unable to form early colonization in lung through the suppressed ICAM-1 function. Taken together, we showed an evidence proving that ubiquitination plays an important role not only in protein degradation but also in signal transduction of a human disease.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (13 results)

All 2010 2009 Other

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (12 results)

  • [Journal Article] Radio-sensitization of the Murine Osteosarcoma Cell Line LM8 with Parthenolide, a Natural Inhibitor of NF-κB.

    • Author(s)
      Sugiyasu K Hashimoto N, Myoui A, Yoshikawa H, et al.
    • Journal Title

      Oncology Letters. in press

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Presentation] NFκB阻害剤パルテノライドによるマウス骨肉腫LM8の放射線感受性増強実験2010

    • Author(s)
      杉安謙仁朗、橋本伸之、名井陽、吉川秀樹, ほか
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-23
    • Related Report
      2010 Final Research Report
  • [Presentation] NFκB阻害剤パルテノライドによるマウス骨肉腫LM8の放射線感受性増強実験2010

    • Author(s)
      杉安謙仁朗, ほか
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪国際会議場
    • Year and Date
      2010-09-23
    • Related Report
      2010 Annual Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBAC)の役割2010

    • Author(s)
      友永真人、橋本伸之、名井陽、吉川秀樹, ほか
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-22
    • Related Report
      2010 Final Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBAC)の役割2010

    • Author(s)
      友永真人, ほか
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪国際会議場
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] NFκB阻害剤パルテノライドによるマウス骨肉腫LM8の放射線感受性増強実験2010

    • Author(s)
      杉安謙仁朗、橋本伸之、名井陽、吉川秀樹, ほか
    • Organizer
      第43回日本整形外科学会骨・軟部腫瘍学術集会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-15
    • Related Report
      2010 Final Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBAC)の役割2010

    • Author(s)
      友永真人、橋本伸之、名井陽、吉川秀樹, ほか
    • Organizer
      第43回日本整形外科学会骨・軟部腫瘍学術集会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-15
    • Related Report
      2010 Final Research Report
  • [Presentation] NFκB阻害剤パルテノライドによるマウス骨肉腫LM8の放射線感受性増強実験2010

    • Author(s)
      杉安謙仁朗, ほか
    • Organizer
      第43回日本整形外科学会 骨・軟部腫瘍学術集会
    • Place of Presentation
      京王プラザホテル、東京
    • Year and Date
      2010-07-15
    • Related Report
      2010 Annual Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBACL)の役割2010

    • Author(s)
      友永真人, ほか
    • Organizer
      第43回日本整形外科学会 骨・軟部腫瘍学術集会
    • Place of Presentation
      京王プラザホテル、東京
    • Year and Date
      2010-07-15
    • Related Report
      2010 Annual Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBAC)の役割2010

    • Author(s)
      友永真人、橋本伸之、名井陽、吉川秀樹, ほか
    • Organizer
      第19回日本がん転移学会
    • Place of Presentation
      金沢市
    • Year and Date
      2010-06-17
    • Related Report
      2010 Final Research Report
  • [Presentation] マウス骨肉腫肺転移における新規NFκB活性化経路(LUBAC)の役割2010

    • Author(s)
      友永真人, ほか
    • Organizer
      第19回日本がん転移学会
    • Place of Presentation
      金沢市文化ホール
    • Year and Date
      2010-06-17
    • Related Report
      2010 Annual Research Report
  • [Presentation] Radio-sensitization of the Murine Osteosarcoma Cell Line LM8 with Parthenolide, a Natural Inhibitor of NF-κB.2010

    • Author(s)
      杉安謙仁朗, 橋本伸之, 名井陽, 吉川秀樹, et al.
    • Organizer
      56^<th> annual meetingof orthopaedic research society
    • Place of Presentation
      New Orleans, USA.
    • Year and Date
      2010-03-07
    • Related Report
      2010 Final Research Report
  • [Presentation] 宿主肺細胞によるマウス骨肉腫細胞LM8のNF-kB活性促進効果2009

    • Author(s)
      友永真人, ほか
    • Organizer
      日本整形外科学会骨・軟部腫瘍学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2009-07-17
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi